About the Liver Transplant Surgeon

Dr. Akanand Singh is a highly respected liver transplant surgeon in Nepal and an Associate Professor of Surgery at KIST Medical College & Teaching Hospital. He is widely recognized for his expertise in hepatobiliary surgery, liver transplantation, and the management of complex liver diseases. Through his clinical practice, research, and teaching, Dr Akanand Singh has contributed significantly to advancing liver transplant services in Nepal.

In addition to his academic role, Dr Akanand Singh serves as a Visiting Consultant at Nepal Mediciti Hospital in Lalitpur and works as a Consultant at National Institute of Health Sciences (NIHS). His involvement in multiple leading healthcare institutions allows him to provide specialized surgical care and advanced treatment options for patients suffering from severe liver diseases.

With years of experience in hepatobiliary surgery, Dr Akanand Singh specializes in living donor liver transplantation (LDLT), treatment of liver cancer, and management of end-stage liver disease. He focuses on improving surgical outcomes, ensuring patient safety, and enhancing transplant success rates.

Dr Akanand Singh specializes in liver transplantation and liver cancer treatment. His research and clinical practice follow internationally accepted medical guidelines and standards, including recommendations from the World Health Organization, ensuring high-quality and ethical healthcare practices.

Professional Experience in Liver Transplant Surgery

Dr Akanand Singh currently holds the following positions:

• Associate Professor of Surgery – KIST Medical College & Teaching Hospital

• Visiting Consultant – Nepal Mediciti Hospital, Lalitpur

• Consultant – National Institute of Health Sciences (NIHS)

Through these roles, he contributes to surgical education, clinical training, and advanced patient care.

Research in Liver Cancer and Transplant Outcomes

Research is an important part of Dr Akanand Singh’s professional career. His key research interests include:

• Small for Size Syndrome (SFSS) in Living Donor Liver Transplantation

• Outcomes of Living Donor Liver Transplant (LDLT)

• Surgical management of Liver Cancer (Hepatocellular Carcinoma)

• Improving graft survival and transplant success rates

His research aims to develop better surgical techniques and predictive tools to improve patient outcomes in liver transplantation.

Selected Scientific Publication

One of the notable scientific publications by Dr Akanand Singh is:

Singh A, Singhal S, Venuthurimilli A, Pareek S, Maung PM, Aung TH, Garg HK, Vohra S, Sahni R, Goyal N.

“HPi: A Novel Parameter to Predict Graft-related Outcome in Adult Living Donor Liver Transplant.”

Published in Transplantation, April 2022;106(4):767-780.
DOI: 10.1097/TP.0000000000003890
PMID: 34260473

This research introduced HPi, a novel predictive parameter used to evaluate graft-related outcomes in adult living donor liver transplantation. The study provides valuable insights that help improve transplant success rates and patient safety.